The short-read sequencing market is booming, projected to reach $26.88 billion by 2033, with a CAGR of 16.4%. This report analyzes market drivers, trends, and key players like Illumina and Thermo Fisher, providing insights into this rapidly expanding sector of genomics. Learn more about NGS technology and its applications in personalized medicine and diagnostics.
We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.